prophylactic DNA vaccine (Powderject)

N/A

Report date: 2025/03/20 09:54:28

Base Information

Drug Nameprophylactic DNA vaccine (Powderject)
Drug Alias NameHBV DNA vaccine (Powderject)prophylactic DNA vaccine (PowderJect/GlaxoSmithKline)HBV prophylactic DNA vaccine (PowderJect/Glaxo Wellcome)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPowderject Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPowderject PharmaceuticalsGlaxosmithkline PlcGlaxo Group Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A